Back to companies
Kalaris Therapeutics, Inc.
KLRSUSNASDAQPharmaceuticals & HealthcareKalaris Therapeutics, Inc.
Revenue
—
FY2025
Operating income
-$46.2mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API